Hassani Mohammad, Mohebbi Mahdi, Tavallaei Mehdi, Nodoushan Seyed Mohammad Reza Hosseini, Mirzadeh Moein, Hashemi Rana
Department of General Surgery, School of Medicine, Ayatollah Taleghani Hospital Research Development Committee, Shahid Beheshti University of Medical Sciences, Tehran.
Department of General Surgery, Alborz University of Medical Sciences, Karaj.
Eur J Transl Myol. 2022 May 19;32(2):10537. doi: 10.4081/ejtm.2022.10537.
Renal transplant therapy is essential in patients with End-Stage Renal Disease (ESRD). It is used in patients awaiting a kidney transplant or those who cannot be a transplant candidate. Central venous catheter is one of the most used access routes worldwide but has been recorded as the one with highest mortality and morbidity rate. Thromboembolic events have played a major part for that. This is a descriptive-analytical study, which conducted in a university treatment center in Tehran, Iran. A total of 225 patients were selected for this study that 108 were excluded because of our criteria. Statistical analysis was performed by SPSS v19 and a total of 117 patients were included in this study. The average age of the patients was 51.62±11.26. 79 (67.5%) and 38 (32.5%) patients had medial and lateral tip direction, respectively. The catheter of 85(72.6%) and 32(27.4%) patients was patent and occluded, respectively. The average catheter tip occlusion time in both groups was 22.5 and 7.5 months. Three-month, six-month, twelve-month, and twenty-four-month patency rate were 99%, 94%, 88%, and 30%, respectively. our findings suggest that medial direction of the tip of the catheter reduces complications caused in CVS. Because our study has been conducted in a small scale and there is lack of similar studies, our team suggests extension to a larger scale to confirm or not our results.
肾移植治疗对于终末期肾病(ESRD)患者至关重要。它用于等待肾移植的患者或那些不适合成为移植候选者的患者。中心静脉导管是全球最常用的通路之一,但已被记录为死亡率和发病率最高的一种。血栓栓塞事件对此起到了主要作用。这是一项描述性分析研究,在伊朗德黑兰的一家大学治疗中心进行。本研究共选取了225例患者,其中108例因我们的标准被排除。使用SPSS v19进行统计分析,本研究共纳入117例患者。患者的平均年龄为51.62±11.26岁。分别有79例(67.5%)和38例(32.5%)患者的导管尖端方向为内侧和外侧。分别有85例(72.6%)和32例(27.4%)患者的导管通畅和堵塞。两组的导管尖端平均堵塞时间分别为22.5个月和7.5个月。三个月、六个月、十二个月和二十四个月的通畅率分别为99%、94%、88%和30%。我们的研究结果表明,导管尖端的内侧方向可减少中心静脉系统引起的并发症。由于我们的研究规模较小且缺乏类似研究,我们团队建议扩大规模以证实或否定我们的结果。